Your browser doesn't support javascript.
loading
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
Petrie, Mark C; Verma, Subodh; Docherty, Kieran F; Inzucchi, Silvio E; Anand, Inder; Belohlávek, Jan; Böhm, Michael; Chiang, Chern-En; Chopra, Vijay K; de Boer, Rudolf A; Desai, Akshay S; Diez, Mirta; Drozdz, Jaroslaw; Dukát, Andre; Ge, Junbo; Howlett, Jonathan; Katova, Tzvetana; Kitakaze, Masafumi; Ljungman, Charlotta E A; Merkely, Béla; Nicolau, Jose C; O'Meara, Eileen; Vinh, Pham Nguyen; Schou, Morten; Tereshchenko, Sergey; Køber, Lars; Kosiborod, Mikhail N; Langkilde, Anna Maria; Martinez, Felipe A; Ponikowski, Piotr; Sabatine, Marc S; Sjöstrand, Mikaela; Solomon, Scott D; Johanson, Per; Greasley, Peter J; Boulton, David; Bengtsson, Olof; Jhund, Pardeep S; McMurray, John J V.
Afiliação
  • Petrie MC; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut.
  • Anand I; Department of Cardiology, University of Minnesota, Minneapolis.
  • Belohlávek J; Second Department of Internal Medicine, Cardiovascular Medicine, General Teaching Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Böhm M; Department of Medicine, Saarland University Hospital, Homburg/Saar, Germany.
  • Chiang CE; Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chopra VK; National Yang-Ming University, Taipei, Taiwan.
  • de Boer RA; Department of Cardiology, Medanta, Gurgaon, Haryana, India.
  • Desai AS; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Diez M; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Drozdz J; Division of Cardiology, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.
  • Dukát A; Department Cardiology, Medical University of Lodz, Lodz, Poland.
  • Ge J; Fifth Department of Internal Medicine, Comenius University in Bratislava, Bratislava, Slovakia.
  • Howlett J; Shanghai Institute of Cardiovascular Disease, Department of Cardiology, Zhongshan Hospital Fudan University, Shanghai, China.
  • Katova T; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Kitakaze M; Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria.
  • Ljungman CEA; Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
  • Merkely B; Institute of Medicine, Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Nicolau JC; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • O'Meara E; Instituto do Coracao (InCor), Hospital das Clínicas Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
  • Vinh PN; Department of Cardiology, Montreal Heart Institute, Montreal, Ontario, Canada.
  • Schou M; Department of Internal Medicine, Tan Tao University, Tan Duc, Vietnam.
  • Tereshchenko S; Department of Cardiology, Gentofte University Hospital Copenhagen, Copenhagen, Denmark.
  • Køber L; Department of Myocardial Disease and Heart Failure, National Medical Research Center of Cardiology, Moscow, Russia.
  • Kosiborod MN; Department of Cardiology Copenhagen University Hospital, Copenhagen, Denmark.
  • Langkilde AM; St Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City.
  • Martinez FA; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Ponikowski P; Universidad Nacional de Córdoba, Córdoba, Argentina.
  • Sabatine MS; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland.
  • Sjöstrand M; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Solomon SD; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Johanson P; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Greasley PJ; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Boulton D; Early Discovery and Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Bengtsson O; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
  • Jhund PS; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
JAMA ; 323(14): 1353-1368, 2020 04 14.
Article em En | MEDLINE | ID: mdl-32219386

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido